Article

Challenges in HIV Drug Adherence

Conference|EADV Congress - European Academy of Dermatology and Venereology Congress

At the 25th European Academy of Dermatology and Venereology Congress in Vienna, Thomas C. Quinn, MD, director of the Johns Hopkins Center for Global Health, discussed hurdles to proper drug adherence in HIV treatment.

At the 25th European Academy of Dermatology and Venereology Congress in Vienna, Thomas C. Quinn, MD, director of the Johns Hopkins Center for Global Health, discussed hurdles to proper drug adherence in HIV treatment.

Related Videos
The EMPOWER-Lung 1 Trial: Five-Year Outcomes of Cemiplimab Monotherapy in Advanced NSCLC
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Related Content
Flu, Influenza, Medication, FDA | Image Credit: Pixel-Shot - stock.adobe.com
October 8th 2024

Baloxavir Marboxil Shows Reduction in Influenza Transmission

Ashley Gallagher, Associate Editor
Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care
July 25th 2024

Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

Eye of the Beholder: Understanding The Subjective Experience of Acute Ketamine Treatment
October 4th 2024

Eye of the Beholder: Understanding The Subjective Experience of Acute Ketamine Treatment

Jack Vinciguerra, PharmD
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
Danon Disease, FDA, Orphan Drug Designation | Image Credit: C Davids/peopleimages.com - stock.adobe.com
October 3rd 2024

FDA Grants Orphan Drug Designation to PPL-002 for the Treatment of Danon Disease

Ashley Gallagher, Associate Editor
Biosimilar Eye Care | Image Credit: Mahachoke 4289-6395 - stock.adobe.com
October 2nd 2024

Data Supports Approval of Biosimilar Aflibercept for Diabetic Macular Edema

Ashley Gallagher, Associate Editor